
  
    
      
        
        Epidemics_NNP of_IN overt_JJ toxicity_NN following_VBG widespread_JJ environmental_JJ contamination_NN from_IN
        commercial_JJ toxins_NNS heralded_VBN the_DT discovery_NN of_IN children_NNS 's_POS enhanced_JJ vulnerability_NN to_TO lead_VB ,_,
        methyl_NN mercury_NN ,_, polychlorinated_JJ biphenyls_NNS (_( PCBs_NNS )_) ,_, and_CC tobacco_NN [_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ]_NN (_( Box_NNP 1_LS )_) ._. Over_IN the_DT
        past_JJ three_CD decades_NNS ,_, researchers_NNS have_VBP found_VBN that_IN remarkably_RB low-level_JJ exposures_NNS to_TO these_DT
        toxins_NNS are_VBP linked_VBN with_IN less_RBR overt_JJ symptoms_NNS of_IN toxicity—intellectual_NN impairments_NNS ,_, behavioral_JJ
        problems_NNS ,_, spontaneous_JJ abortions_NNS ,_, or_CC preterm_NN births_NNS [_NN 6_CD ,_, 7_CD ,_, 8_CD ,_, 9_CD ,_, 10_CD ,_, 11_CD ,_, 12_CD ,_, 13_CD ,_, 14_CD ,_,
        15_CD ,_, 16_CD ,_, 17_CD ,_, 18_CD ,_, 19_CD ,_, 20_CD ,_, 21_CD ,_, 22_CD ,_, 23_CD ,_, 24_CD ,_, 25_CD ,_, 26_CD ,_, 27_CD ,_, 28_CD ,_, 29_CD ,_, 30_CD ,_, 31_CD ,_, 32_CD ,_, 33_CD ,_, 34_CD ,_, 35_CD ,_, 36_CD ,_, 37_CD ,_, 38_CD ,_, 39_CD ,_, 40_CD ]_NN ._. Moreover_RB ,_,
        there_EX is_VBZ emerging_VBG evidence_NN that_IN decrements_NNS in_IN intellectual_JJ abilities_NNS and_CC low_JJ birth_NN weight_NN
        linked_VBN with_IN lead_NN or_CC tobacco_NN are_VBP ,_, for_IN a_DT given_VBN increment_NN of_IN exposure_NN ,_, greater_JJR at_IN lower_JJR levels_NNS
        than_IN those_DT found_VBN at_IN higher_JJR levels_NNS [_NN 10_CD ,_, 41_CD ,_, 42_CD ,_, 43_CD ]_NN ._.
        The_DT consequences_NNS of_IN exposure_NN to_TO many_JJ other_JJ chemicals_NNS or_CC mixtures_NNS of_IN chemicals_NNS ,_, such_JJ as_IN
        insecticides—chemicals_NNS oftentimes_NNS specifically_RB designed_VBN to_TO be_VB toxic—are_NN largely_RB unknown_JJ
        [_NN 33_CD ,_, 34_CD ,_, 35_CD ,_, 44_CD ]_NN ._. Many_JJ of_IN these_DT chemicals_NNS or_CC their_PRP$ metabolites_NNS are_VBP routinely_RB found_VBN in_IN the_DT
        blood_NN and_CC body_NN fluids_NNS of_IN pregnant_JJ women_NNS and_CC children_NNS [_NN 45_CD ]_NN ._.
      
      
        Children_NNP 's_POS Vulnerability_NNP to_TO Environmental_NNP Toxins_NNP
        The_DT developing_VBG fetus_NN and_CC young_JJ child_NN is_VBZ particularly_RB vulnerable_JJ to_TO certain_JJ environmental_JJ
        toxins_NNS [_NN 46_CD ,_, 47_CD ,_, 48_CD ,_, 49_CD ,_, 50_CD ]_NN ._. Critical_JJ neurodevelopmental_NN processes_VBZ occur_VB in_IN the_DT human_JJ central_JJ
        nervous_JJ system_NN during_IN fetal_JJ development_NN and_CC in_IN the_DT first_JJ three_CD years_NNS of_IN life_NN ._. These_DT
        processes_NNS include_VBP cortical_JJ functional_JJ differentiation_NN ,_, synaptogenesis_NNS ,_, myelination_NN ,_, and_CC
        programmed_VBN apoptosis_NNS [_NN 46_CD ]_NN ._.
        Children_NNP 's_POS exposure_NN to_TO environmental_JJ toxins_NNS is_VBZ insidious_JJ ._. Environmental_JJ toxins_NNS covertly_RB
        enter_VBP a_DT child_NN 's_POS body_NN transplacentally_RB during_IN fetal_JJ development_NN or_CC by_IN direct_JJ ingestion_NN of_IN
        house_NN dust_NN ,_, soil_NN ,_, and_CC breastmilk_NN and_CC other_JJ dietary_JJ sources_NNS during_IN early_JJ childhood_NN
        [_NN 51_CD ,_, 52_CD ,_, 53_CD ,_, 54_CD ,_, 55_CD ,_, 56_CD ]_NN ._. Our_PRP$ ability_NN to_TO directly_RB measure_VB the_DT actual_JJ levels_NNS of_IN environmental_JJ
        chemicals_NNS in_IN human_JJ tissues_NNS and_CC body_NN fluids_NNS using_VBG biologic_JJ markers_NNS (_( biomarkers_NNS )_) enables_VBZ
        scientists_NNS to_TO more_RBR effectively_RB link_NN exposures_NNS to_TO environmental_JJ toxins_NNS with_IN disability_NN or_CC
        disease_NN [_NN 57_CD ]_NN ._.
        Despite_IN our_PRP$ increased_VBN knowledge_NN of_IN the_DT toxicity_NN of_IN environmental_JJ chemicals_NNS ,_, testing_NN for_IN
        developmental_NN neurotoxicity_NN (_( DNT_NNP )_) and_CC reproductive_JJ toxicity_NN is_VBZ rarely_RB done_VBN ._. DNT_NNP testing_NN
        uses_VBZ animal_NN experiments_NNS to_TO provide_VB information_NN on_IN the_DT potential_JJ functional_JJ and_CC morphologic_JJ
        toxicity_NN to_TO the_DT fetal_JJ nervous_JJ system_NN that_IN results_NNS from_IN the_DT mother_NN 's_POS exposure_NN to_TO toxins_NNS
        during_IN pregnancy_NN and_CC lactation_NN ._. Paradoxically_NNP ,_, DNT_NNP testing_NN of_IN a_DT chemical_NN is_VBZ seldom_RB
        requested_VBN ,_, and_CC then_RB typically_RB requested_VBD only_RB if_IN there_EX is_VBZ pre-existing_JJ evidence_NN that_IN it_PRP is_VBZ
        neurotoxic_JJ ._.
      
      
        The_DT Prevalence_NNP of_IN Diseases_NNP and_CC Disabilities_NNPS Linked_NNP to_TO Environmental_NNP Toxins_NNP
        Based_VBN on_IN parental_JJ reports_NNS ,_, one_CD in_IN six_CD United_NNP States_NNPS children_NNS has_VBZ one_CD or_CC more_JJR
        developmental_NN disabilities_NNS ,_, from_IN a_DT subtle_JJ learning_NN disability_NN to_TO overt_JJ behavioral_JJ or_CC
        emotional_JJ disorders_NNS [_NN 58_CD ]_NN ._. Exposures_NNP to_TO environmental_JJ toxins_NNS have_VBP been_VBN linked_VBN with_IN higher_JJR
        rates_NNS of_IN mental_JJ retardation_NN ,_, intellectual_JJ impairment_NN ,_, and_CC behavioral_JJ problems_NNS ,_, such_JJ as_IN
        conduct_NN disorder_NN and_CC attention_NN deficit_NN hyperactivity_NN disorder_NN [_NN 16_CD ,_, 17_CD ,_, 18_CD ,_,
        19_CD ,_, 20_CD ,_, 21_CD ,_, 22_CD ,_, 23_CD ,_, 24_CD ,_, 25_CD ,_, 26_CD ,_, 27_CD ,_, 30_CD ,_, 31_CD ,_, 36_CD ,_, 37_CD ,_, 38_CD ,_, 39_CD ,_, 40_CD ,_, 41_CD ,_, 42_CD ,_, 43_CD ,_, 59_CD ,_, 60_CD ,_, 61_CD ]_NN ._.
        One_CD in_IN ten_CD US_NNP babies_NNS is_VBZ born_VBN preterm_NN and_CC about_IN 5_CD %_NN have_VBP low_JJ birth_NN weight_NN [_NN 62_CD ,_, 63_CD ]_NN ._. Preterm_NNP
        birth_NN ,_, defined_VBN as_IN birth_NN at_IN less_JJR than_IN 37_CD weeks_NNS of_IN gestation_NN ,_, is_VBZ a_DT major_JJ determinant_NN of_IN
        infant_NN mortality_NN and_CC morbidity_NN throughout_IN childhood_NN [_NN 62_CD ,_, 63_CD ,_, 64_CD ]_NN ._. Exposures_NNP to_TO environmental_JJ
        toxins_NNS such_JJ as_IN lead_NN ,_, tobacco_NN smoke_NN ,_, and_CC DDT_NNP have_VBP been_VBN linked_VBN with_IN an_DT increased_VBN risk_NN for_IN
        spontaneous_JJ abortion_NN ,_, low_JJ birth_NN weight_NN ,_, or_CC preterm_NN birth_NN [_NN 6_CD ,_, 9_CD ,_, 10_CD ,_, 13_CD ,_, 14_CD ,_, 15_CD ,_, 28_CD ,_, 32_CD ,_, 65_CD ,_, 66_CD ]_NN ._. The_DT
        rate_NN of_IN occurrence_NN for_IN many_JJ of_IN these_DT diseases_NNS or_CC disabilities_NNS has_VBZ been_VBN rising_VBG ,_, as_IN has_VBZ
        treatment_NN for_IN attention_NN deficit_NN hyperactivity_NN disorder_NN and_CC depression_NN in_IN children_NNS
        [_NN 62_CD ,_, 63_CD ,_, 67_CD ,_, 68_CD ,_, 69_CD ,_, 70_CD ]_NN ._.
        Multiple_NNP risk_NN factors_NNS ,_, including_VBG both_DT genetic_JJ and_CC environmental_JJ influences_NNS ,_, interact_NN in_IN
        complex_JJ and_CC often_RB unknown_JJ ways_NNS to_TO cause_VB disease_NN and_CC disability_NN in_IN children_NNS ._. But_CC efforts_NNS can_MD
        be_VB undertaken_VBN to_TO prevent_VB or_CC reduce_VB environmental_JJ exposures_NNS linked_VBN to_TO disease_NN without_IN full_JJ
        elucidation_NN of_IN the_DT underlying_VBG mechanism_NN [_NN 71_CD ]_NN ._. Thus_RB ,_, conducting_VBG some_DT sort_NN of_IN test_NN to_TO
        identify_VB pesticides_NNS and_CC industrial_JJ chemicals_NNS that_WDT could_MD cause_VB reproductive_JJ or_CC
        neurobehavioral_NN toxicity_NN before_IN the_DT chemical_NN reaches_VBZ widespread_JJ use_NN is_VBZ essential_JJ to_TO protect_VB
        pregnant_JJ women_NNS and_CC children_NNS ._.
      
      
        Origin_NNP and_CC Evolution_NNP of_IN DNT_NNP Tests_NNP
        The_DT process_NN for_IN testing_NN potential_JJ developmental_NN neurotoxins_NNS in_IN laboratory_NN animals_NNS
        evolved_VBD out_IN of_IN a_DT series_NN of_IN tragic_JJ epidemics_NNS ._. Widespread_NNP use_NN of_IN the_DT drug_NN thalidomide_NN during_IN
        the_DT 1950_CD s_VBZ led_VBN to_TO an_DT epidemic_NN of_IN phocomelia_NN ,_, an_DT absence_NN or_CC deformity_NN of_IN limbs_NNS and_CC other_JJ
        congenital_NN defects_NNS in_IN children_NNS exposed_VBN in_IN utero_NN to_TO the_DT drug_NN [_NN 72_CD ]_NN ._. Subsequently_RB ,_, in_IN 1965_CD ,_,
        the_DT Food_NNP and_CC Drug_NNP Administration_NNP (_( FDA_NNP )_) developed_VBD the_DT Teratology_NNP Guidelines_NNS ._. Because_IN
        thalidomide_NN induced_VBD gross_JJ defects_NNS in_IN rabbits_NNS but_CC not_RB in_IN rats_NNS ,_, these_DT guidelines_NNS called_VBN for_IN
        toxicity_NN tests_NNS in_IN two_CD species_NNS ._. Moreover_RB ,_, these_DT guidelines_NNS focused_VBN on_IN gross_JJ abnormalities_NNS ;_:
        they_PRP did_VBD not_RB require_VB testing_NN for_IN behavioral_JJ or_CC DNT_NNP ._.
        Following_VBG the_DT outbreak_NN of_IN methyl_NN mercury_NN poisoning_NN in_IN Minamata_NNP Bay_NNP (_( Box_NNP 1_LS )_) ,_, Japan_NNP and_CC
        the_DT United_NNP Kingdom_NNP added_VBD behavioral_JJ (_( DNT_NNP )_) guidelines_NNS to_TO their_PRP$ teratology_NN requirements_NNS in_IN
        1974_CD and_CC 1975_CD ,_, respectively_RB [_NN 73_CD ]_NN ._. In_IN 1978_CD ,_, the_DT Collaborative_NNP Behavioral_NNP Teratology_NNP Study_NNP
        (_( CBTS_NNP )_) was_VBD conceived_VBN to_TO standardize_VB and_CC evaluate_VB methods_NNS for_IN DNT_NNP testing_NN in_IN the_DT US_NNP [_NN 74_CD ]_NN ._.
        The_DT final_JJ report_NN was_VBD issued_VBN in_IN 1985_CD ,_, and_CC shortly_RB thereafter_RB ,_, Dr_NNP ._. Donald_NNP Kennedy_NNP ,_, who_WP was_VBD
        then_RB Commissioner_NNP of_IN the_DT FDA_NNP ,_, supported_VBD the_DT adoption_NN of_IN the_DT CBTS_NNP recommendations_NNS ._. But_CC the_DT
        FDA_NNP failed_VBD to_TO implement_VB these_DT recommendations_NNS after_IN Kennedy_NNP 's_POS departure_NN ._.
        
          Children_NNP 's_POS exposure_NN to_TO environmental_JJ toxins_NNS is_VBZ insidious_JJ
        
        In_IN 1990_CD ,_, the_DT US_NNP Environmental_NNP Protection_NNP Agency_NNP (_( EPA_NNP )_) identified_VBN nine_CD developmental_NN
        neurobehavioral_NN teratogens_NNS for_IN both_DT humans_NNS and_CC animals_NNS (_( lead_VB ,_, PCBs_NNS ,_, methyl_NN mercury_NN ,_,
        cocaine_NN ,_, alcohol_NN ,_, phenytoin_NN ,_, heroin_NN ,_, methadone_NN ,_, and_CC ionizing_VBG radiation_NN )_) and_CC developed_VBN rules_NNS
        for_IN DNT_NNP testing_NN in_IN laboratory_NN animals_NNS [_NN 49_CD ,_, 50_CD ]_NN ._. By_IN 1991_CD ,_, the_DT Developmental_NNP Neurotoxicity_NNP
        Test_NNP Guidelines_NNS (_( OPPTS_NNP 870_CD ._. 6300_CD )_) had_VBD been_VBN established_VBN for_IN use_NN when_WRB submitting_VBG chemical_NN data_NNS
        to_TO the_DT EPA_NNP [_NN 49_CD ]_NN ._. In_IN 1993_CD ,_, the_DT National_NNP Research_NNP Council_NNP recommended_VBD that_IN DNT_NNP data_NNS be_VB
        included_VBN in_IN the_DT EPA_NNP 's_POS evaluations_NNS of_IN pesticides_NNS ,_, which_WDT include_VBP classes_NNS of_IN chemicals_NNS
        specifically_RB designed_VBN to_TO be_VB toxic_JJ [_NN 44_CD ]_NN ._.
      
      
        The_DT Precarious_NNP US_NNP Framework_NNP for_IN Protecting_NNP Children_NNP
        Despite_IN numerous_JJ attempts_NNS to_TO upgrade_VB the_DT regulatory_JJ system_NN ,_, such_JJ as_IN the_DT CBTS_NNP ,_, the_DT
        framework_NN to_TO protect_VB children_NNS from_IN environmental_JJ toxins_NNS is_VBZ precarious_JJ ._. Under_IN current_JJ
        regulations_NNS ,_, manufacturers_NNS of_IN commercial_JJ chemicals_NNS (_( excluding_VBG pesticides_NNS )_) are_VBP not_RB required_VBN
        to_TO supply_VB any_DT toxicity_NN data_NN before_IN selling_VBG their_PRP$ products_NNS ._. Nor_CC are_VBP pesticide_NN manufacturers_NNS
        obligated_VBN to_TO supply_VB basic_JJ premarket_NN toxicity_NN and_CC exposure_NN data_NNS necessary_JJ to_TO ensure_VB that_IN
        children_NNS will_MD be_VB protected_VBN from_IN exposure_NN and_CC potential_JJ harm_NN from_IN use_NN of_IN those_DT pesticides_NNS ._.
        Indeed_RB ,_, the_DT vast_JJ majority_NN of_IN chemicals_NNS have_VBP not_RB been_VBN tested_VBN for_IN DNT_NNP ._. The_DT most_RBS basic_JJ
        toxicity_NN tests_NNS in_IN animals_NNS are_VBP lacking_VBG for_IN 75_CD %_NN of_IN the_DT 3_CD ,_, 000_CD highest_JJS production_NN volume_NN
        chemicals—chemicals_NNS for_IN which_WDT annual_JJ production_NN exceeds_VBZ 1_CD million_CD pounds_NNS per_IN year_NN
        [_NN 49_CD ,_, 75_CD ,_, 76_CD ,_, 77_CD ]_NN ._. The_DT US_NNP EPA_NNP has_VBZ entered_VBN into_IN an_DT agreement_NN with_IN the_DT American_NNP Chemistry_NNP
        Council_NNP ,_, the_DT chemical_NN manufacturer_NN 's_POS trade_NN association_NN ,_, to_TO provide_VB basic_JJ toxicity_NN screening_NN
        tests_NNS for_IN the_DT high-production-volume_JJ chemicals_NNS by_IN 2005_CD
        (_( http_NN :_: /_NN /_NN www_NN ._. epa_NN ._. gov_NN /_NN chemrtk_NN /_NN volchall_NN ._. htm_NN )_) ,_, but_CC this_DT is_VBZ voluntary_JJ ._.
        For_IN new_JJ pesticides_NNS intended_VBN for_IN use_NN on_IN food_NN crops—one_NN of_IN the_DT areas_NNS in_IN which_WDT regulations_NNS
        are_VBP most_JJS stringent—regulations_NNS require_VBP only_RB that_IN DNT_NNP testing_NN be_VB evaluated_VBN for_IN substances_NNS
        already_RB known_VBN or_CC suspected_VBN of_IN being_VBG toxins_NNS ._. Further_RB ,_, neurotoxicity_NN testing_NN need_VBP be_VB
        conducted_VBN only_RB in_IN adult_NN animals_NNS ._. The_DT EPA_NNP acknowledges_VBZ that_IN over_IN 140_CD registered_VBN pesticides_NNS
        are_VBP neurotoxic_JJ (_( i_NNP ._. e_SYM ._. ,_, specifically_RB designed_VBN to_TO act_VB against_IN pests_NNS by_IN interfering_VBG with_IN
        neurotransmitters_NNS or_CC other_JJ processes_VBZ shared_VBN by_IN mammals_NNS and_CC insects_NNS )_) ,_, but_CC the_DT EPA_NNP has_VBZ
        received_VBN DNT_NNP testing_NN using_VBG validated_JJ protocols_NNS for_IN only_RB nine_CD pesticides_NNS [_NN 49_CD ,_, 75_CD ,_, 76_CD ,_, 77_CD ]_NN ._.
        There_EX is_VBZ no_DT general_JJ requirement_NN that_IN pesticides_NNS or_CC other_JJ chemicals_NNS be_VB tested_VBN for_IN
        potential_JJ DNT_NNP prior_RB to_TO their_PRP$ registration_NN and_CC use_NN [_NN 49_CD ]_NN ._. For_IN pesticides—which_NN undergo_VBP more_JJR
        premarket_NN testing_NN than_IN other_JJ chemicals—the_NN EPA_NNP has_VBZ relied_VBN on_IN a_DT tiered_JJ system_NN of_IN toxicity_NN
        testing_NN ._. The_DT assumption_NN underlying_VBG this_DT system_NN is_VBZ that_IN positive_JJ findings_NNS on_IN earlier_RBR ,_, more_RBR
        basic_JJ tests_NNS of_IN neurotoxicity_NN in_IN adult_NN animals_NNS will_MD “ trigger_VB” the_DT EPA_NNP to_TO request_VB more_RBR
        extensive_JJ testing_NN by_IN manufacturers_NNS ,_, including_VBG tests_NNS in_IN immature_NN animals_NNS ._. Unfortunately_RB ,_,
        this_DT tiered_JJ process_NN has_VBZ failed_VBN to_TO result_VB in_IN appropriate_JJ DNT_NNP testing_NN ._. In_IN 1998_CD ,_, an_DT internal_JJ
        EPA_NNP Toxicology_NNP Working_NNP Group_NNP concluded_VBD that_IN these_DT triggers_VBZ may_MD not_RB be_VB sufficient_JJ to_TO
        identify_VB all_DT chemicals_NNS that_WDT have_VBP the_DT potential_NN to_TO produce_VB DNT_NNP [_NN 75_CD ]_NN ._. Moreover_RB ,_, this_DT tiered_JJ
        system_NN discourages_VBZ industry_NN from_IN conducting_VBG testing_NN in_IN immature_NN animals_NNS because_IN the_DT
        findings_NNS could_MD necessitate_NN further_JJ costly_JJ testing_NN and_CC hinder_VB a_DT chemical_NN from_IN reaching_VBG the_DT
        market_NN ._.
      
      
        The_DT European_NNP Framework_NNP :_: “ REACH_NNP”
        In_IN 2001_CD ,_, the_DT European_NNP Commission_NNP affirmed_VBD that_IN the_DT European_NNP Union_NNP 's_POS legislative_JJ
        framework_NN did_VBD not_RB provide_VB adequate_JJ information_NN about_IN the_DT adverse_JJ effects_NNS of_IN chemicals_NNS on_IN
        human_JJ health_NN ,_, and_CC that_IN when_WRB hazards_NNS were_VBD identified_VBN the_DT regulatory_JJ agencies_NNS were_VBD slow_JJ to_TO
        assess_VB risks_NNS and_CC to_TO introduce_VB measures_NNS to_TO reduce_VB those_DT risks_NNS [_NN 78_CD ]_NN ._. Indeed_RB ,_, chemical_NN
        manufacturers_NNS are_VBP not_RB required_VBN to_TO “ prove_VB” that_IN a_DT chemical_NN is_VBZ safe_JJ before_IN marketing_VBG it_PRP ._. The_DT
        European_NNP Commission_NNP proposed_VBD a_DT new_JJ regulatory_JJ framework_NN for_IN chemicals_NNS ,_, REACH_NNP (_( Registration_NNP ,_,
        Evaluation_NNP ,_, and_CC Authorization_NNP of_IN Chemicals_NNPS )_) [_NN 78_CD ,_, 79_CD ]_NN (_( Figure_NN 1_LS )_) ._.
        Under_IN REACH_NNP ,_, chemical_NN manufacturers_NNS would_MD have_VB to_TO assume_VB a_DT much_RB greater_JJR burden_NN for_IN
        showing_VBG the_DT lack_NN of_IN harm_NN from_IN use_NN of_IN their_PRP$ products_NNS ._. Specifically_RB ,_, REACH_NNP would_MD require_VB both_DT
        European_JJ and_CC non-_NN European_JJ manufacturers_NNS doing_VBG business_NN in_IN Europe_NNP to_TO submit_VB more_RBR extensive_JJ
        toxicity_NN data_NNS for_IN about_IN 30_CD ,_, 000_CD chemicals_NNS on_IN the_DT market_NN ,_, including_VBG reproductive_JJ and_CC DNT_NNP data_NNS
        for_IN those_DT chemicals_NNS produced_VBN in_IN highest_JJS quantity_NN ._. Chemicals_NNS found_VBD to_TO be_VB hazardous_JJ would_MD be_VB
        subject_JJ to_TO an_DT authorization_NN procedure_NN to_TO show_VB that_IN they_PRP can_MD be_VB used_VBN safely_RB or_CC that_IN there_EX
        are_VBP no_DT safer_JJR alternatives_NNS ._. This_DT registration_NN process_NN would_MD not_RB guarantee_VB that_IN chemicals_NNS are_VBP
        safe_JJ ,_, but_CC it_PRP is_VBZ a_DT step_NN in_IN the_DT right_JJ direction_NN ._.
        The_DT American_NNP Chemistry_NNP Council_NNP has_VBZ objections_NNS to_TO REACH_NNP ,_, stating_VBG that_IN “ the_DT proposed_VBN
        regulation_NN is_VBZ burdensome_JJ ,_, costly_JJ ,_, and_CC impractical_JJ”
        (_( http_NN :_: /_NN /_NN www_NN ._. accnewsmedia_NN ._. com_NN /_NN site_NN /_NN page_NN ._. asp_NN ?_. TRACKID_NNP =_SYM &_CC VID_NNP =_SYM 1_CD &_CC CID_NNP =_SYM 359_CD &_CC DID_NNP =_SYM 1256_CD )_) ._.
        The_DT pharmaceutical_JJ industry_NN used_VBD similar_JJ objections_NNS to_TO ward_VB off_RP regulations_NNS before_IN the_DT
        thalidomide_NN epidemic_NN ushered_VBD in_IN requirements_NNS for_IN pharmaceutical_JJ agents_NNS to_TO undergo_VB extensive_JJ
        premarket_NN testing_NN in_IN clinical_JJ trials_NNS [_NN 80_CD ]_NN ._.
      
      
        Limitations_NNPS of_IN Existing_JJ Animal_NNP Tests_NNP for_IN DNT_NNP
        The_DT US_NNP EPA_NNP has_VBZ been_VBN slower_JJR than_IN the_DT EU_NNP to_TO adapt_VB to_TO the_DT overwhelming_JJ evidence_NN that_IN
        low-level_JJ exposure_NN to_TO environmental_JJ toxins_NNS can_MD be_VB harmful_JJ ._. The_DT EPA_NNP continues_VBZ to_TO rely_VB
        heavily_RB on_IN data_NNS from_IN animal_NN (_( toxicity_NN )_) testing_NN conducted_VBN on_IN only_RB a_DT single_JJ animal_NN species_NNS
        and_CC in_IN adult_NN animals_NNS ._. Furthermore_RB ,_, EPA_NNP guidelines_NNS for_IN a_DT general_JJ developmental_NN toxicity_NN
        screening_NN test_NN typically_RB examine_VB only_RB crude_NN toxicological_JJ endpoints_NNS such_JJ as_IN death_NN ,_, body_NN
        weight_NN ,_, or_CC organ_NN dysfunction_NN ._. In_IN contrast_NN ,_, the_DT DNT_NNP includes_VBZ tests_NNS of_IN locomotor_NN activity_NN ,_,
        acoustic_JJ startle_NN ,_, learning_VBG ,_, and_CC memory_NN ._. But_CC ,_, as_RB currently_RB designed_VBN ,_, the_DT existing_VBG tests_NNS may_MD
        miss_VB important_JJ effects_NNS such_JJ as_IN mood_NN changes_NNS ,_, impulsive_JJ behaviors_NNS ,_, and_CC attentional_NN problems_NNS
        that_IN in_IN humans_NNS have_VBP been_VBN shown_VBN to_TO result_VB from_IN exposures_NNS to_TO environmental_JJ toxins_NNS
        [_NN 24_CD ,_, 27_CD ,_, 30_CD ,_, 37_CD ,_, 40_CD ]_NN ._. While_IN these_DT effects_NNS might_MD seem_VB subtle_JJ ,_, they_PRP can_MD seriously_RB interfere_VB with_IN
        a_DT child_NN 's_POS social_JJ and_CC emotional_JJ well-being_NN ._. It_PRP is_VBZ also_RB uncertain_JJ whether_IN tests_NNS conducted_VBN
        under_IN current_JJ EPA_NNP guidelines_NNS will_MD detect_VB subtle_JJ deficits_NNS in_IN key_JJ human_JJ skills_NNS such_JJ as_IN
        reading_NN ._.
        There_EX are_VBP other_JJ problems_NNS with_IN relying_VBG principally_RB on_IN adult_NN animals_NNS to_TO signal_VB the_DT
        potential_NN for_IN DNT_NNP in_IN humans_NNS ._. The_DT structure_NN and_CC development_NN of_IN the_DT cerebral_JJ cortex_NN of_IN
        animals_NNS commonly_RB used_VBN in_IN these_DT studies_NNS differs_VBZ markedly_RB from_IN that_DT of_IN humans_NNS ._. A_DT chemical_NN 's_POS
        effects_NNS on_IN one_CD type_NN of_IN animal_NN may_MD differ_VB from_IN its_PRP$ effects_NNS on_IN other_JJ animals_NNS and_CC on_IN humans_NNS ._.
        In_IN the_DT case_NN of_IN thalidomide_NN ,_, high-dose_JJ fetal_JJ exposure_NN had_VBD adverse_JJ morphologic_JJ effects_NNS on_IN
        rabbits_NNS ,_, but_CC not_RB rats_NNS ;_: functional_JJ effects_NNS have_VBP only_RB recently_RB been_VBN described_VBN [_NN 81_CD ]_NN ._.
        Although_IN there_EX is_VBZ some_DT concordance_NN of_IN human_NN and_CC animal_NN data_NNS for_IN the_DT adverse_JJ effects_NNS of_IN
        lead_NN ,_, mercury_NN ,_, and_CC PCBs_NNS ,_, intake_NN limits_NNS for_IN these_DT compounds_NNS established_VBN exclusively_RB on_IN the_DT
        basis_NN of_IN rodent_NN studies_NNS have_VBP not_RB been_VBN sufficiently_RB protective_JJ of_IN human_JJ health_NN compared_VBN with_IN
        epidemiologic_JJ studies_NNS [_NN 47_CD ]_NN ._. Indeed_RB ,_, there_EX is_VBZ compelling_JJ evidence_NN from_IN epidemiologic_JJ studies_NNS
        of_IN widespread_JJ contaminants_NNS such_JJ as_IN lead_NN ,_, tobacco_NN ,_, and_CC PCBs_NNS that_IN human_JJ studies_NNS are_VBP essential_JJ
        to_TO ensure_VB that_IN children_NNS are_VBP not_RB harmed_VBN by_IN low_JJ levels_NNS of_IN exposure_NN
        [_NN 11_CD ,_, 12_CD ,_, 13_CD ,_, 14_CD ,_, 15_CD ,_, 16_CD ,_, 17_CD ,_, 18_CD ,_, 19_CD ,_, 20_CD ,_, 21_CD ,_, 22_CD ,_, 23_CD ,_, 24_CD ,_, 25_CD ,_, 26_CD ,_, 27_CD ,_, 28_CD ,_, 29_CD ,_, 30_CD ,_, 31_CD ,_, 32_CD ,_, 33_CD ,_, 34_CD ,_, 35_CD ,_,
        36_CD ,_, 37_CD ,_, 38_CD ,_, 39_CD ,_, 40_CD ]_NN ._.
        From_IN a_DT scientific_JJ standpoint_NN ,_, data_NNS from_IN epidemiologic_JJ studies_NNS represent_VBP the_DT “ gold_NN
        standard_JJ” for_IN detecting_VBG subtle_JJ effects_NNS of_IN environmental_JJ toxins_NNS on_IN humans_NNS ._. But_CC
        epidemiological_JJ studies_NNS are_VBP expensive_JJ to_TO mount_VB ,_, difficult_JJ to_TO execute_VB ,_, and_CC take_VB years_NNS to_TO
        complete_VB ._. Using_VBG observational_NN studies_NNS to_TO disentangle_NN the_DT adverse_JJ consequences_NNS of_IN a_DT single_JJ
        toxin_NN from_IN other_JJ environmental_JJ influences_VBZ and_CC to_TO promulgate_NN regulations_NNS is_VBZ a_DT difficult_JJ and_CC
        painfully_RB slow_JJ process_NN ._. There_EX is_VBZ also_RB a_DT financial_JJ disincentive_JJ for_IN chemical_NN registrants_NNS to_TO
        voluntarily_RB fund_VB such_JJ studies_NNS because_IN a_DT positive_JJ epidemiological_JJ study_NN could_MD lead_VB to_TO
        stricter_JJR regulations_NNS ._. More_RBR importantly_RB ,_, if_IN society_NN continues_VBZ to_TO rely_VB on_IN epidemiologic_JJ
        studies_NNS to_TO evaluate_VB the_DT toxicity_NN of_IN chemicals_NNS only_RB after_IN they_PRP are_VBP marketed_VBN ,_, many_JJ children_NNS
        will_MD first_RB be_VB harmed_VBN ._.
      
      
        Steps_VBZ to_TO Protect_NNP Children_NNP from_IN Environmental_NNP Toxins_NNP
        Children_NNP must_MD be_VB better_RBR protected_JJ from_IN both_DT new_JJ and_CC existing_VBG chemicals_NNS that_WDT are_VBP known_VBN or_CC
        possible_JJ toxins_NNS [_NN 49_CD ]_NN ._. To_TO protect_VB children_NNS from_IN existing_VBG toxins_NNS ,_, such_JJ as_IN lead_NN ,_, mercury_NN ,_, and_CC
        tobacco_NN ,_, the_DT US_NNP EPA_NNP and_CC FDA_NNP need_VBP more_JJR authority_NN and_CC resources_NNS to_TO regulate_VB and_CC reduce_VB
        emissions_NNS and_CC exposures_NNS ._. Under_IN our_PRP$ current_JJ system_NN ,_, efforts_NNS to_TO enhance_VB regulations_NNS to_TO
        protect_VB children_NNS from_IN confirmed_VBD toxins_NNS are_VBP costly_JJ and_CC protracted_JJ ._. Indeed_RB ,_, countless_JJ
        communities_NNS across_IN the_DT globe_NN suffer_VB from_IN widespread_JJ environmental_JJ contamination_NN ._. If_IN there_EX
        is_VBZ any_DT lesson_NN from_IN our_PRP$ experience_NN with_IN environmental_JJ toxins_NNS ,_, it_PRP is_VBZ that_IN we_PRP need_VBP to_TO identify_VB
        environmental_JJ chemicals_NNS that_WDT are_VBP toxic_JJ before_IN they_PRP are_VBP marketed_VBN or_CC widely_RB disseminated_VBN ._.
        For_IN new_JJ commercial_JJ chemicals_NNS ,_, toxicity_NN testing_NN in_IN animals_NNS should_MD be_VB required_VBN before_IN they_PRP
        are_VBP marketed_VBN ._. For_IN all_DT new_JJ chemicals_NNS ,_, including_VBG pesticides_NNS ,_, extensive_JJ premarket_NN testing_NN
        should_MD be_VB required_VBN in_IN multiple_JJ animal_NN species_NNS of_IN both_DT sexes_NNS and_CC at_IN different_JJ developmental_NN
        stages_NNS ._. These_DT tests_NNS should_MD be_VB designed_VBN to_TO have_VB adequate_JJ statistical_JJ power_NN to_TO detect_VB subtle_JJ
        differences_NNS within_IN the_DT ranges_NNS of_IN exposure_NN that_WDT occur_VBP in_IN human_JJ populations_NNS ._. If_IN implemented_VBN ,_,
        these_DT testing_NN requirements_NNS would_MD represent_VB a_DT dramatic_JJ departure_NN from_IN existing_VBG regulations_NNS ,_,
        while_IN providing_VBG a_DT powerful_JJ incentive_NN for_IN industry_NN to_TO develop_VB less_RBR toxic_JJ chemicals_NNS ._.
        Toxicity_NNP testing_NN in_IN animals_NNS is_VBZ essential_JJ but_CC insufficient_JJ to_TO protect_VB pregnant_JJ women_NNS and_CC
        children_NNS ._. For_IN one_CD thing_NN ,_, uncertainties_NNS about_IN the_DT safety_NN of_IN a_DT chemical_NN for_IN humans_NNS will_MD
        persist_VB even_RB after_IN toxicity_NN testing_NN in_IN animals_NNS is_VBZ successfully_RB completed_VBN ._. One_CD additional_JJ
        safeguard_VB that_WDT deserves_VBZ further_JJ debate_NN is_VBZ whether_IN prevalent_JJ environmental_JJ chemicals_NNS to_TO
        which_WDT children_NNS could_MD be_VB exposed_VBN should_MD undergo_VB more_RBR extensive_JJ testing_NN in_IN human_JJ trials_NNS
        before_IN they_PRP are_VBP marketed_VBN ._. If_IN done_VBN ,_, these_DT trials_NNS should_MD examine_VB exposure_NN ,_, uptake_NN (_( using_VBG
        biomarkers_NNS )_) ,_, and_CC adverse_JJ effects_NNS among_IN children_NNS or_CC other_JJ populations_NNS only_RB when_WRB the_DT product_NN
        is_VBZ used_VBN as_IN intended_VBN ._. For_IN example_NN ,_, once_RB animal_NN toxicity_NN testing_NN of_IN a_DT residential_JJ pesticide_NN
        is_VBZ complete_JJ (_( including_VBG DNT_NNP and_CC reproductive_JJ toxicity_NN testing_NN )_) ,_, a_DT pesticide_NN could_MD undergo_VB
        further_JJ testing_NN in_IN the_DT home_NN environment_NN ._. Using_VBG an_DT experimental_JJ group_NN and_CC a_DT control_NN group_NN ,_,
        researchers_NNS would_MD compare_VB levels_NNS of_IN pesticides_NNS found_VBD in_IN settled_VBN dust_NN ,_, on_IN children_NNS 's_POS hands_NNS ,_,
        and_CC in_IN their_PRP$ blood_NN ,_, urine_NN ,_, or_CC hair_NN ._. Children_NNP would_MD be_VB followed_VBN ,_, when_WRB indicated_VBD ,_, to_TO ensure_VB
        that_IN an_DT excess_NN of_IN neurobehavioral_NN problems_NNS or_CC other_JJ relevant_JJ outcomes_NNS did_VBD not_RB develop_VB among_IN
        those_DT whose_WP$ homes_NNS were_VBD assigned_VBN to_TO receive_VB the_DT pesticide_NN application_NN ._.
        If_IN such_JJ trials_NNS were_VBD undertaken_VBN ,_, families_NNS would_MD need_VB to_TO be_VB fully_RB informed_VBN about_IN the_DT
        purpose_NN ,_, potential_JJ benefits_NNS ,_, and_CC risks_NNS of_IN participating_VBG ._. The_DT trials_NNS should_MD be_VB conducted_VBN by_IN
        the_DT federal_JJ government—or_NN other_JJ independent_JJ entities_NNS that_WDT do_VBP not_RB have_VB any_DT ties_NNS to_TO the_DT
        chemical_NN industry—and_NN funded_VBN by_IN an_DT industry_NN fee_NN or_CC tax_NN ._. Community_NN representatives_NNS would_MD
        need_VB to_TO be_VB involved_VBN in_IN the_DT review_NN and_CC approval_NN of_IN such_JJ trials_NNS ,_, and_CC ethical_JJ standards_NNS would_MD
        need_VB to_TO be_VB established_VBN regarding_VBG ,_, for_IN example_NN ,_, the_DT role_NN of_IN data_NNS safety_NN and_CC monitoring_VBG
        boards_NNS ._. Many_JJ families_NNS would_MD undoubtedly_RB find_VB it_PRP objectionable_JJ and_CC would_MD choose_VB not_RB to_TO
        participate_VB ._. Indeed_RB ,_, some_DT products_NNS might_MD never_RB undergo_VB testing_NN if_IN they_PRP failed_VBD to_TO offer_VB
        meaningful_JJ benefits_NNS to_TO families_NNS ,_, in_IN which_WDT case_NN the_DT product_NN would_MD either_CC be_VB taken_VBN off_IN the_DT
        market_NN or_CC never_RB reach_VB the_DT market_NN ._.
        This_DT type_NN of_IN trial_NN sounds_VBZ extreme_JJ ,_, but_CC it_PRP is_VBZ quite_RB rational_JJ when_WRB compared_VBN to_TO the_DT
        existing_VBG approach_NN of_IN disseminating_VBG a_DT potential_JJ toxin_NN into_IN children_NNS 's_POS environments_NNS without_IN
        any_DT human_JJ data_NN about_IN exposure_NN ,_, uptake_NN ,_, or_CC toxicity_NN ._. Furthermore_RB ,_, under_IN our_PRP$ existing_VBG system_NN ,_,
        families_NNS are_VBP neither_DT informed_VBN nor_CC given_VBN an_DT option_NN to_TO decline_VB involvement_NN in_IN what_WP ultimately_RB
        are_VBP experiments_NNS exposing_VBG millions_NNS of_IN pregnant_JJ women_NNS and_CC children_NNS to_TO potential_JJ toxins_NNS ._. Thus_RB ,_,
        we_PRP need_VBP to_TO thoughtfully_RB deliberate_JJ about_IN whether_IN these_DT types_NNS of_IN trials_NNS can_MD be_VB done_VBN in_IN an_DT
        ethical_JJ fashion_NN ._. We_PRP also_RB need_VBP to_TO have_VB further_JJ debate_NN about_IN whether_IN it_PRP is_VBZ ethical_JJ to_TO
        continue_VB to_TO disseminate_VB chemicals_NNS of_IN unknown_JJ toxicity_NN into_IN children_NNS 's_POS environments_NNS or_CC to_TO
        allow_VB children_NNS to_TO continually_RB be_VB exposed_VBN to_TO prevalent_JJ toxins_NNS ,_, like_IN lead_NN ,_, despite_IN
        considerable_JJ evidence_NN that_IN they_PRP are_VBP toxic_JJ [_NN 82_CD ]_NN ._. Too_RB often_RB ,_, it_PRP is_VBZ left_VBN up_IN to_TO a_DT few_JJ
        investigators_NNS or_CC community_NN leaders_NNS to_TO discover_VB and_CC quantify_VB the_DT adverse_JJ effects_NNS of_IN toxins_NNS ,_,
        and_CC advocate_NN efforts_NNS to_TO reduce_VB children_NNS 's_POS exposure_NN ._.
      
      
        Conclusion_NNP
        In_IN contrast_NN with_IN the_DT EU_NNP 's_POS proposed_VBN REACH_NNP program_NN ,_, which_WDT would_MD require_VB industry_NN to_TO
        conduct_VB more_JJR tests_NNS or_CC analyses_NNS to_TO demonstrate_VB that_IN high-production_JJ chemicals_NNS will_MD not_RB cause_VB
        harm_NN to_TO fetuses_NNS or_CC children_NNS ,_, the_DT Bush_NNP administration_NN has_VBZ argued—in_NN unison_NN with_IN the_DT American_NNP
        Chemistry_NNP Council—that_NNP such_JJ regulations_NNS would_MD harm_VB industry_NN [_NN 83_CD ,_, 84_CD ]_NN ._. It_PRP is_VBZ time_NN to_TO
        acknowledge_VB that_IN the_DT existing_VBG requirements_NNS for_IN toxicity_NN testing_NN and_CC regulations_NNS are_VBP
        inadequate_JJ to_TO safeguard_VB pregnant_JJ women_NNS and_CC children_NNS ._. Until_IN a_DT formal_JJ regulatory_JJ system_NN is_VBZ
        developed_VBN to_TO effectively_RB screen_VB and_CC identify_VB new_JJ and_CC existing_VBG chemicals_NNS that_WDT are_VBP toxic_JJ to_TO
        pregnant_JJ women_NNS and_CC children_NNS ,_, we_PRP are_VBP left_VBN to_TO await_VB the_DT next_JJ epidemic_NN to_TO warn_VB us_PRP about_IN an_DT
        environmental_JJ disaster_NN ._. Unfortunately_RB ,_, by_IN then_RB we_PRP will_MD have_VB once_RB again_RB fouled_VBN our_PRP$ nest_NN
        [_NN 85_CD ]_NN ._.
      
    
  
